BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29169331)

  • 1. Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry.
    Hwong WY; Abdul Aziz Z; Sidek NN; Bots ML; Selvarajah S; Kappelle LJ; Sivasampu S; Vaartjes I
    BMC Neurol; 2017 Nov; 17(1):203. PubMed ID: 29169331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prescription at discharge improves long-term adherence for secondary stroke prevention.
    Tsai JP; Rochon PA; Raptis S; Bronskill SE; Bell CM; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2308-15. PubMed ID: 25149205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.
    Dalli LL; Kim J; Thrift AG; Andrew NE; Lannin NA; Anderson CS; Grimley R; Katzenellenbogen JM; Boyd J; Lindley RI; Pollack M; Jude M; Durairaj R; Shah D; Cadilhac DA; Kilkenny MF
    Stroke; 2019 Dec; 50(12):3592-3599. PubMed ID: 31648630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.
    Sjölander M; Eriksson M; Glader EL
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):911-9. PubMed ID: 22069216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy prior to and in acute ischaemic stroke. The use of pharmacotherapy and drug-associated outcomes in real world practice - findings from the Polish Hospital Stroke Registry.
    Niewada M; Sarzyńska-Długosz IM; Skowrońska M; Kamiński B; Kobayashi A; Członkowska A
    Neurol Neurochir Pol; 2013; 47(6):509-16. PubMed ID: 24374995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the Use of Medications for Secondary Ischemic Stroke Prevention in Denmark, 2005-2021.
    Skajaa N; Laugesen K; Lauffenburger JC; Schwamm LH; Sørensen HT; Patorno E
    Neurology; 2024 May; 102(9):e209309. PubMed ID: 38648572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders.
    Zupanic E; Kramberger MG; von Euler M; Norrving B; Winblad B; Secnik J; Fastbom J; Eriksdotter M; Garcia-Ptacek S
    J Alzheimers Dis; 2020; 73(3):1013-1021. PubMed ID: 31884483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
    Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
    PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.
    Glader EL; Sjölander M; Eriksson M; Lundberg M
    Stroke; 2010 Feb; 41(2):397-401. PubMed ID: 20075360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatments in the secondary prevention of ischaemic stroke.
    Schulz UG
    Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Demographic Characteristics Associated With Suboptimal Primary Stroke and Transient Ischemic Attack Prevention: Retrospective Analysis.
    Turner GM; Calvert M; Feltham MG; Ryan R; Finnikin S; Marshall T
    Stroke; 2018 Mar; 49(3):682-687. PubMed ID: 29440471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic Trends in Hospitalized Ischemic Stroke from 2002 to 2010: Results from a Large Italian Population-Based Study.
    Santalucia P; Baviera M; Cortesi L; Tettamanti M; Marzona I; Nobili A; Riva E; Fortino I; Bortolotti A; Merlino L; Roncaglioni MC
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1917-23. PubMed ID: 26051662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive Versus Moderate Statin Therapy Discontinuation in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
    Yuan HW; Ji RJ; Lin YJ; Chen HF; Peng GP; Luo BY
    Clin Ther; 2018 Dec; 40(12):2041-2049. PubMed ID: 30420288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.